Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes

This study has been terminated.

( Slow accrual. )

Study NCT00038870 Information provided by M.D. Anderson Cancer Center

First Received: June 5, 2002 Last Updated: October 20, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	January 2003
Primary Completion Date:	January 2003 (Final data collection date for primary outcome measure)